Relevant bibliographies by topics / Pharmaceutical company

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Pharmaceutical company'

Author: Grafiati
Published: 4 June 2021
Last updated: 26 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Pharmaceutical company.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Pharmaceutical company"

1

Deuskar, Vishwa. "Comparative Profitability Analysis: Sun Pharmaceutical Company & Cipla Pharmaceutical Company." RESEARCH REVIEW International Journal of Multidisciplinary 7, no. 8 (2022): 109–14. http://dx.doi.org/10.31305/rrijm.2022.v07.i08.017.

Full text
Abstract:
The Indian pharmaceutical industry is growing tremendously. Indian pharmaceutical industry plays a prominent role in the global pharmaceutical industry. It contributes to the welfare of people and provides significant socio-economic benefits to the society through creation of jobs, supply chains and community development. This study has been done for important evaluation of two Indian giant pharmaceutical industries i.e. Sun pharmaceutical Ltd. and Cipla pharmaceuticals. This study focuses on to analyze the profitability of the selected pharmaceutical companies of India and to do comparative s
APA, Harvard, Vancouver, ISO, and other styles
2

Sadler, John Z. "Pharmaceutical Company Influence." Hastings Center Report 41, no. 2 (2011): S22. http://dx.doi.org/10.1353/hcr.2011.0054.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Erle, Henry R. "A modern pharmaceutical company." Clinical Pharmacology [amp ] Therapeutics 71, no. 1 (2002): 103. http://dx.doi.org/10.1067/mcp.2002.120165.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

SHAPIRO, J. D., K.-A. PHILLIPS, and I. F. TANNOCK. "More pharmaceutical company influence?" Australian and New Zealand Journal of Medicine 28, no. 5 (1998): 675. http://dx.doi.org/10.1111/j.1445-5994.1998.tb00676.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Saravanan, Dr S., and R. Prabhu. "A Study on Financial Performance of Pharmaceutical Company." International Journal of Trend in Scientific Research and Development Volume-2, Issue-3 (2018): 1904–7. http://dx.doi.org/10.31142/ijtsrd11425.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Shantanu R. Kulkarni. "Implementation of Track and Trace Systems at Pharmaceuticals Industry Ltd." Journal of Information Systems Engineering and Management 10, no. 19s (2025): 834–41. https://doi.org/10.52783/jisem.v10i19s.3120.

Full text
Abstract:
The pharmaceutical industry faces significant challenges in ensuring its products' safety, authenticity, and regulatory compliance. global pharmaceutical company has implemented advanced Track and Trace (T&T) systems to enhance supply chain visibility, combat counterfeiting, and ensure patient safety. This journal explores the key strategies, technological frameworks, and benefits of implementing T&T systems at global pharmaceuticals company. The paper also examines the regulatory landscape influencing T&T adoption and the challenges encountered during implementation.
APA, Harvard, Vancouver, ISO, and other styles
7

Kwon, Ki-Hwan, Ga-Yeon Kim, Ju-Hee Oh, Hye-Min Lee, Yeon-Jin Lim, and Mun-Hyeon Jeong. "CELLTRION: Towards Global Pharmaceutical Company." Korea Business Review 25, no. 2 (2021): 1–32. http://dx.doi.org/10.17287/kbr.2021.25.2.1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Rosenblatt, Michael. "The Large Pharmaceutical Company Perspective." New England Journal of Medicine 376, no. 1 (2017): 52–60. http://dx.doi.org/10.1056/nejmra1510069.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Schulte, Lorraine. "A New Pharmaceutical Company Library." Science & Technology Libraries 7, no. 1 (1986): 15–30. http://dx.doi.org/10.1300/j122v07n01_03.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Sykes, R. "Being a modern pharmaceutical company." BMJ 317, no. 7167 (1998): 1172–80. http://dx.doi.org/10.1136/bmj.317.7167.1172.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Pharmaceutical company"

1

Månsson, Thorsén Törnqvist Niclas Erik Mikael. "Employee Branding at a pharmaceutical company." Thesis, Internationella Handelshögskolan, Högskolan i Jönköping, IHH, EMM (Entreprenörskap, Marknadsföring, Management), 2010. http://urn.kb.se/resolve?urn=urn:nbn:se:hj:diva-13376.

Full text
Abstract:
This bachelor thesis in business administration investigates the employee branding process of Company X in order to gain an understanding of how the company works with and can utilize this as an efficient tool. Recent research shows that Swedish companies that focus on building their brands are more profitable than companies that do not. Furthermore, re- search show that relationship building is an increasingly important area of marketing, which means that employees have a key role in creating a brand through the relationships they build. As Company X to some extent relies on relationship buil
APA, Harvard, Vancouver, ISO, and other styles
2

Pinho, Bárbara Marina da Silva. "Regulatory affairs role in a multinational pharmaceutical company." Master's thesis, Universidade de Aveiro, 2014. http://hdl.handle.net/10773/12967.

Full text
Abstract:
Mestrado em Biomedicina Farmacêutica<br>The present monograph intends to present a Regulatory Affairs department at a Multinational Pharmaceutical Company, as well as the role of the professionals working in that department. The experience which led to this monograph occurred after the conclusion of the curricular part of the Masters in Pharmaceutical Medicine, and was an opportunity to apply all the knowledge previously acquired and to develop new technical and personal skills. After the contextualisation of this document, the first chapter of this monograph introduce the Regulatory Affairs P
APA, Harvard, Vancouver, ISO, and other styles
3

Wang, Xiaojun M. Eng Massachusetts Institute of Technology. "Inventory management in a pharmaceutical company : minimizing discard practices." Thesis, Massachusetts Institute of Technology, 2010. http://hdl.handle.net/1721.1/62513.

Full text
Abstract:
Thesis (M. Eng.)--Massachusetts Institute of Technology, Dept. of Mechanical Engineering, 2010.<br>Cataloged from PDF version of thesis.<br>Includes bibliographical references (p. 63).<br>Pharmaceutical company SPM has over 400 cases of inventory discards over the past five years which constitute a significant operating cost. Due to the complexity and randomness of each case, the root causes that result in inventory discards are not identified by the management, thereby hindering SPM from coming up with effective discard minimization practices. This thesis investigates the discard reasons and
APA, Harvard, Vancouver, ISO, and other styles
4

Batista, Cátia Sofia Santos. "Curricular training report: pharmaceutical industry & spin-off company." Master's thesis, Universidade de Aveiro, 2013. http://hdl.handle.net/10773/11624.

Full text
Abstract:
Mestrado em Biomedicina Farmacêutica<br>O presente relatório expõe as atividades desenvolvidas durante o estágio curricular, frequentado na Bluepharma - Indústria Farmacêutica S.A. e na TREAT U, Lda. uma Spin-off da Universidade de Coimbra, no âmbito do Mestrado em Biomedicina Farmacêutica da Universidade de Aveiro. Esta foi uma experiência de 6 meses que teve duas componentes, uma multidisciplinar e outra monodisciplinar, as quais me permitiram desenvolver os conhecimentos e aptidões adquiridas ao longo do curso de mestrado e de as aplicar ao mundo real. Para além do desenvolvimento de compe
APA, Harvard, Vancouver, ISO, and other styles
5

Faruk, Hossan, and Ahsan Habib. "Performance evaluation and ratio analysis of Pharmaceutical Company in Bangladesh." Thesis, University West, Department of Economics and Informatics, 2010. http://urn.kb.se/resolve?urn=urn:nbn:se:hv:diva-2516.

Full text
Abstract:
<p>The thesis applies performance evaluation of pharmaceutical company in Bangladesh. It means evaluate how well the company performs. The main aim is achieved through ratio analysis of two pharmaceutical (Beximco and Square pharmaceutical) companies in Bangladesh. The main data collection from the annual financial reports on Beximco and square pharmaceutical companies in 2007 to 2008.Different financial ratio are evaluated such liquidity ratios, asset management ratios, profitability ratios, market value ratios, debt management ratios and finally measure the best performance between two compa
APA, Harvard, Vancouver, ISO, and other styles
6

Campos, Joana da Palma. "HRM practices in employees' centered outcomes : a pharmaceutical company analysis." Master's thesis, FEUC, 2014. http://hdl.handle.net/10316/27516.

Full text
Abstract:
Relatório de estágio do mestrado em Gestão, apresentado à Faculdade de Economia da Universidade de Coimbra, sob a orientação de Teresa Carla Oliveira e Bruno Néné.<br>O presente relatório foi elaborado como parte integrante do Mestrado em Gestão da Faculdade de Economia da Universidade de Coimbra no âmbito de um estágio curricular com duração de cinco meses desenvolvido durante o 2º semestre de 2014 no departamento de Recursos Humanos da Bluepharma, Indústria Farmacêutica S.A. Esta actividade de formação e desenvolvimento contemplou um conjunto de actividades, entre as quais destacamos a orga
APA, Harvard, Vancouver, ISO, and other styles
7

Jagun, Charles. "Strategies for Compliance with Government Regulations in a Pharmaceutical Company." ScholarWorks, 2018. https://scholarworks.waldenu.edu/dissertations/5352.

Full text
Abstract:
Pharmaceutical companies accrued fines of over $30 billion within 25 years because of noncompliance with regulations. Noncompliance with regulations results in fines and an adverse impact on company profitability. Some pharmaceutical company managers lack effective strategies to ensure overall company compliance with regulation. Based on complexity leadership theory, the purpose of this single case study was to explore strategies pharmaceutical company managers used to ensure compliance with regulatory requirements in Nigeria. The target population was functional managers purposely selected be
APA, Harvard, Vancouver, ISO, and other styles
8

Zhu, Jing Hua. "The strategy analysis of the most successful J-V pharmaceutical company (Xian-Janssen Pharmaceutical Ltd.) in China." Thesis, University of Macau, 2001. http://umaclib3.umac.mo/record=b1636679.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Pang, Xiaoshuang, and Yunpeng Qu. "Marketing Innovation Implementation : A case study of a Chinese Pharmaceutical Company." Thesis, University of Gävle, Department of Industrial Development, IT and Land Management, 2010. http://urn.kb.se/resolve?urn=urn:nbn:se:hig:diva-7468.

Full text
Abstract:
<p>Innovation is becoming more and more important in modern society. There is a lot of research on different kinds of innovation. Marketing innovation is one kind of innovation that has not been studied frequently before. One useful definition of marketing innovation is new ways which companies can market themselves to potential or existing customers (Halpern, 2010). This thesis focuses on the implementation process of marketing innovation. The research questions are: Which elements will be helpful or obstructive to the implementation process of marketing innovation? How will these positive or
APA, Harvard, Vancouver, ISO, and other styles
10

Hu, He M. Eng Massachusetts Institute of Technology. "IBC management : an application of WIP control for a pharmaceutical company." Thesis, Massachusetts Institute of Technology, 2008. http://hdl.handle.net/1721.1/46154.

Full text
Abstract:
Thesis (M. Eng.)--Massachusetts Institute of Technology, Dept. of Mechanical Engineering, 2008.<br>Includes bibliographical references (leaf 70).<br>An Intermediate Bulk Container (IBC) is used to contain raw materials and semi-products in pharmaceutical company ABC. Due to the high price of an IBC, company ABC sought to minimize the number of IBCs needed to support the production of four separate products. In this project, we identify five IBCs drivers that affect or determine the number of IBCs required. The cleaning schedule for IBCs was modified to reuse IBCs as much as possible. In this p
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Pharmaceutical company"

1

Huotari, Maija-Leena. Information management and competitive advantage: A Finnish pharmaceutical company. University of Tampere, Dept. of Information Studies, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

C, Kirk James, Gale Frederick M, Mabry George A, and Parexel International Corporation, eds. Partnerships in clinical trials: Pharmaceutical company and managed care alliances. PAREXEL International Corporation, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Reinert, Thomas. Encounter with Bayer: Historical aspects of an innovation company. Frankfurter Allgemeine Buch, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Langill, Ellen. The F. Dohmen Company: A tradition of innovation. F. Dohmen Company, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Knut, Sogner, ed. Wealth of contrasts: Nyegaard & Co. : a Norwegian Pharmaceutical Company, 1874-1985. Ad Notam Gyldendal, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

D, Flack John, and Jennings Richard 1948-, eds. Modern strategy for preclinical pharmaceutical R&D: Towards the virtual research company. Wiley, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment. Granting additional market exclusivity to the drug Ansaid: Hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 20, 1992. U.S. G.P.O., 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hicks, Karen M. Surviving the Dalkon shield IUD: Women v. the pharmaceutical industry. Teachers College Press, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Office, General Accounting. Prescription drugs: Drug company programs help some people who lack coverage : report to Congressional Requesters. U.S. General Accounting Office, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ramachandran, J. Internationalization from emerging nations: Evidence of strategic entrepreneurship. Indian Institute of Management Bangalore, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Pharmaceutical company"

1

Nahler, Gerhard. "pharmaceutical company." In Dictionary of Pharmaceutical Medicine. Springer Vienna, 2009. http://dx.doi.org/10.1007/978-3-211-89836-9_1036.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Rothman, Tiran. "Company B: Pharmaceutical/Biologics." In Valuations of Early-Stage Companies and Disruptive Technologies. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-38847-8_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Rothman, Tiran. "Company A: Pharmaceutical/New Compounds." In Valuations of Early-Stage Companies and Disruptive Technologies. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-38847-8_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Caillet, Tanguy. "SCM in a Pharmaceutical Company." In Springer Texts in Business and Economics. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-55309-7_25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Nahler, Gerhard. "Company Core Data Sheet (CCDS)." In Dictionary of Pharmaceutical Medicine. Springer Vienna, 2009. http://dx.doi.org/10.1007/978-3-211-89836-9_248.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Nahler, Gerhard. "Company Core Safety Information (CCSI)." In Dictionary of Pharmaceutical Medicine. Springer Vienna, 2009. http://dx.doi.org/10.1007/978-3-211-89836-9_249.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Li, Jian, and Alan Paisey. "System Design for a Pharmaceutical Company." In Transfer Pricing in China. Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-13-7689-4_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Tarallo, Stephen C. "Validation in a Small Pharmaceutical Company." In Handbook of Validation in Pharmaceutical Processes, 4th ed. CRC Press, 2021. http://dx.doi.org/10.1201/9781003163138-65.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

McColgan, Mark. "Leading Operational Excellence in a Global Company." In Leading Pharmaceutical Operational Excellence. Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-35161-7_26.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

White, Anthony R. "The Pharmaceutical Company Approach to Antibiotic Policies." In Antibiotic Policies. Springer US, 2005. http://dx.doi.org/10.1007/0-387-22852-7_34.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Pharmaceutical company"

1

Oni, Nicholas, Samuel Ady Sanjaya, and Fransiscus Ati Halim. "Design and Development of a Web-Based Inventory System Using Agile Methodology and Hybrid Databases for a Pharmaceutical Company." In 2024 11th International Conference on Information Technology, Computer, and Electrical Engineering (ICITACEE). IEEE, 2024. https://doi.org/10.1109/icitacee62763.2024.10762763.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Chen, Ling, and Paul Crook. "The Influence of Post-Weld Heat Treatments (PWHT) upon the Resistance of Ni-Mo and Ni-Cr-Mo Alloys to Chloride-Induced Stress Corrosion Cracking, Pitting, and Crevice Attack." In CORROSION 2021. AMPP, 2021. https://doi.org/10.5006/c2021-16420.

Full text
Abstract:
Abstract The wrought, nickel-molybdenum (Ni-Mo) and nickel-chromium-molybdenum (Ni-Cr-Mo) alloys are very important materials of construction in the chemical process, pharmaceutical, petrochemical, and oil and gas industries. The objective of this study is to compare the resistance of “as welded” and PWHT samples of several alloys to chloride-induced stress corrosion cracking (SCC), pitting, and crevice corrosion, using standard ASTM test procedures. Commercial alloys HASTELLOY® B-3® (UNS N10675)*, C-22® (UNS N06022)*, C-276 (UNS N10276)*, C-2000 ® (UNS N06200) *, G-35® (UNS N06035)* and HYBRI
APA, Harvard, Vancouver, ISO, and other styles
3

Blair, Matthew, and Dimitrios I. Gerogiorgis. "Cost-optimal Solvent Selection for Batch Cooling Crystallisation of Flurbiprofen." In The 35th European Symposium on Computer Aided Process Engineering. PSE Press, 2025. https://doi.org/10.69997/sct.170946.

Full text
Abstract:
Choosing suitable solvents for crystallisation processes can be a challenging task when developing new pharmaceuticals, given the vast number of candidates available. To streamline this task, however, process modelling tools can be used to systematically probe the behaviour of different crystallisation setups entirely in-silico. In fact, it is possible to couple thermodynamic models with basic solid-liquid equilibria (SLE) principles to determine the impact of key process variables (e.g., temperature and solvent choice) on process performance, prior to conducting lab-scale experiments. In ligh
APA, Harvard, Vancouver, ISO, and other styles
4

Pasieka, Engelbert, and Sebastian Engell. "Evolutionary Algorithm Based Real-time Scheduling via Simulation-Optimization for Multiproduct Batch Plants." In The 35th European Symposium on Computer Aided Process Engineering. PSE Press, 2025. https://doi.org/10.69997/sct.183349.

Full text
Abstract:
Production scheduling in the process industry is an area of significant activity in research and of great practical importance for the performance of industrial companies. In the vast majority of research papers, the scheduling problem is formulated as an off-line problem where a number of jobs is scheduled on a number of resources and the efficiency of the formulation and the solution algorithms is discussed. In reality, however, scheduling is a continuous activity that has to react to the arrival of new orders, to variations in processing times, breakdowns, lack of resources etc. This is ter
APA, Harvard, Vancouver, ISO, and other styles
5

Chen, Ning, and Shuo Huang. "Pharmaceutical E-Business in China: a Case of a Pharmaceutical E-Commerce Company." In 2006 International Conference on Service Systems and Service Management. IEEE, 2006. http://dx.doi.org/10.1109/icsssm.2006.320641.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Zheng, Jiaxin. "Research on the bonds of Hengrui Pharmaceutical Company." In Proceedings of the International Conference on Information Economy, Data Modeling and Cloud Computing, ICIDC 2022, 17-19 June 2022, Qingdao, China. EAI, 2022. http://dx.doi.org/10.4108/eai.17-6-2022.2322864.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Halbsguth, C., and C. Zahner. "Industry's perspective Particular challenges for a pharmaceutical company." In GA 2017 – Book of Abstracts. Georg Thieme Verlag KG, 2017. http://dx.doi.org/10.1055/s-0037-1608024.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Guilherme Semedo, Maria, João Rui Pita, and Ana Leonor Pereira. "Quality assessment of quinine sulfate samples in 19th and early 20th centuries in Portugal: the role of the Lusitanian Pharmaceutical Society." In 46th INTERNATIONAL CONGRESS FOR THE HISTORY OF PHARMACY. Pharmaceutical Association of Serbia, 2024. http://dx.doi.org/10.46793/ishp46.155s.

Full text
Abstract:
Cinchona bark-derived medicines such as quinine sulfate were the only effective and widely used antimalarial treatments until the mid-twentieth century. The aim of this communication is to find and discuss references to quality control of quinine sulfate samples in a Portuguese pharmaceutical journal. For this purpose, we analyzed the Jornal da Sociedade Pharmaceutica Lusitana (Journal of the Lusitanian Pharmaceutical Society). This was an important Portuguese journal, edited by the Lusitanian Pharmaceutical Society, a pharmacist’s organization (1838-1933). This journal reflects Portuguese pha
APA, Harvard, Vancouver, ISO, and other styles
9

Berger, M., M. Mokhtar, C. Zahler, M. M. R. Al-Najami, D. Krüger, and K. Hennecke. "Solar process steam for a pharmaceutical company in Jordan." In SOLARPACES 2015: International Conference on Concentrating Solar Power and Chemical Energy Systems. Author(s), 2016. http://dx.doi.org/10.1063/1.4949189.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Asgeirsson, Eyjolfur Ingi, Gudrun Sjofn Axelsdottir, and Hlynur Stefansson. "Automating a manual production scheduling process at a pharmaceutical company." In 2011 Ieee Workshop On Computational Intelligence In Production And Logistics Systems - Part Of 17273 - 2011 Ssci. IEEE, 2011. http://dx.doi.org/10.1109/cipls.2011.5953358.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Pharmaceutical company"

1

Lubowa, Nasser, Zita Ekeocha, Stephen Robert Byrn, and Kari L. Clase. Pharmaceutical Industry in Uganda: A Review of the Common GMP Non-conformances during Regulatory Inspections. Purdue University, 2021. http://dx.doi.org/10.5703/1288284317442.

Full text
Abstract:
The prevalence of substandard medicines in Africa is high but not well documented. Low and Middle-Income Countries (LMICs) are likely to face considerable challenges with substandard medications. Africa faces inadequate drug regulatory practices, and in general, compliance with Good Manufacturing Practices (GMP) in most of the pharmaceutical industries is lacking. The majority of pharmaceutical manufacturers in developing countries are often overwhelmed by the GMP requirements and therefore are unable to operate in line with internationally acceptable standards. Non-conformances observed durin
APA, Harvard, Vancouver, ISO, and other styles
2

Tulum, Öner, and William Lazonick. Setting Pharmaceutical Drug Prices: What the Medicare Negotiators Need to Know About Innovation and Financialization. Institute for New Economic Thinking Working Paper Series, 2024. http://dx.doi.org/10.36687/inetwp226.

Full text
Abstract:
Mandated by the Inflation Reduction Act of 2022, the U.S. government through the Centers for Medicare and Medicaid Services (CMS) is negotiating with pharmaceutical companies over the “maximum fair price” of ten drugs in wide use by Medicare patients. Over the next few years, the number of drugs whose prices are subject to negotiations will increase. The pharmaceutical companies contend that a “fair” price would be a “value-based price” that enables the companies’ shareholders to capture the value that the drug creates for society. Invoking the dominant “maximizing shareholder value” ideology,
APA, Harvard, Vancouver, ISO, and other styles
3

Lichtenberg, Frank, and Joel Waldfogel. Does Misery Love Company? Evidence from pharmaceutical markets before and after the Orphan Drug Act. National Bureau of Economic Research, 2003. http://dx.doi.org/10.3386/w9750.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Agu, Monica, Zita Ekeocha, Stephen Robert Byrn, and Kari L. Clase. The Impact of Mentoring as a GMP Capability Building Tool in The Pharmaceutical Manufacturing Industry in Nigeria. Purdue University, 2012. http://dx.doi.org/10.5703/1288284317447.

Full text
Abstract:
Good Manufacturing Practices (GMP), a component of Pharmaceutical Quality Systems, is aimed primarily at managing and minimizing the risks inherent in pharmaceutical manufacture to ensure the quality, safety and efficacy of products. Provision of adequate number of personnel with the necessary qualifications/practical experience and their continuous training and evaluation of effectiveness of the training is the responsibility of the manufacturer. (World Health Organization [WHO], 2014; International Organization for Standardization [ISO], 2015). The classroom method of training that has been
APA, Harvard, Vancouver, ISO, and other styles
5

Mbabzi, Kikundwa Emma. Standardisation of Staff Training to Increase Efficiency. Purdue University, 2021. http://dx.doi.org/10.5703/1288284317427.

Full text
Abstract:
In any industry or organization, personnel training is emphasized with reference to National Regulatory Authorities (NRAs) guidelines and other globally accepted guidelines. In spite of many refresher training programs, the pharmaceutical industry still faces significant variations in individual/ team efficiency and productivity. Individuals/teams given the same task, SOPs, environment and materials continue to produce significantly different results reflecting the possibility of operating on different sets of theoretical and practical information, which may stem from differing trainer, traini
APA, Harvard, Vancouver, ISO, and other styles
6

Milsom, Penelope, and David McCoy. Corporate accountability in global health governance? A case study of the Access to Medicine Index (Addendum). United Nations University - International Institute for Global Health, 2025. https://doi.org/10.37941/rr/2025/2.

Full text
Abstract:
In October 2024, UNU-IIGH published an extensive analysis of the 2022 Access to Medicine Index (AtMI) and the underlying theory of how the Index promotes increasingly socially responsible corporate policies and practices over time. The analysis identified several limitations of 2022 AtMI. These included: data quality concerns about incomplete and reliable data; a lack of clarity about how data are translated into company scores for each indicator; the low standards against which companies are assessed; and the narrow scope of corporate conduct covered by the Index. While noting some improvemen
APA, Harvard, Vancouver, ISO, and other styles
7

Wang, Yilan, Sijing Zhao, Zherui Shen, Zhenxing Wang, and Fei Wang. Combination of Jinshuibao Capsules and Conventional Pharmaceutical Treatments for Patients with Stable Chronic Obstructive Pulmonary Disease: A Systematic Review and a Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.10.0117.

Full text
Abstract:
Review question / Objective: Jinshuibao capsules are derived from Cordyceps, and they have been widely used in the treatment of different diseases. They have also been utilized in the treatment of respiratory diseases, while their effects on patients with stable chronic obstructive pulmonary disease (COPD) have remained elusive. The present study aimed to compare the efficacy of Jinshuibao capsules plus conventional pharmaceutical treatments (CPT) versus CPT alone for patients with stable COPD. Information sources: It was attempted to conduct a systematic review and a meta-analysis based on th
APA, Harvard, Vancouver, ISO, and other styles
8

Zhang, Cheng, and Yue Yang. Impact of adaptive design on reducing the duration of clinical trials in rare cancers: a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.2.0081.

Full text
Abstract:
Review question / Objective: Whether the application of adaptive design in clinical trials of rare cancers can shorten the duration of clinical trials? Condition being studied: Currently, the development of innovative drug products (InMPs) for rare cancers faces many challenges, including the difficulty of enrolling sufficient numbers of patients from small and heterogeneous patient populations for clinical trials, and the significant risks of high financial investment, long development times and potential failure from a pharmaceutical company's perspective for rare cancer drugs due to limited
APA, Harvard, Vancouver, ISO, and other styles
9

Collington, Rosie, and William Lazonick. Pricing for Medicine Innovation: A Regulatory Approach to Support Drug Development and Patient Access. Institute for New Economic Thinking Working Paper Series, 2022. http://dx.doi.org/10.36687/inetwp176.

Full text
Abstract:
The United States represents the world’s largest market for pharmaceutical drugs. It is also the only advanced economy in the world that does not regulate drug prices. There is no upper threshold for the prices of medicines in the United States. List prices are instead set by manufacturers in negotiation with supply-chain intermediaries, though some federal programs have degrees of discretion in price determinations. In practice, this deregulated system means that drug prices in the United States are generally far higher than in other advanced economies, adversely affecting patient accessibili
APA, Harvard, Vancouver, ISO, and other styles
10

Albors Alonso, Marta, and Pilar Paricio Esteban. La comunicación de la prevención de salud en los programas de responsabilidad social corporativa de empresas farmacéuticas implantadas en España. El caso de Novartis, Roche, Sanofi, Grifols / Health risk prevention awareness communication from the Corporate Social Responsibility programs, of the pharmaceutical companys set in Spain. The case of Novartis, Roche, Sanofi and Grifols. Revista Internacional de Relaciones Públicas, 2016. http://dx.doi.org/10.5783/rirp-11-2016-04-47-72.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Pharmaceutical company' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography